{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:47:40Z","timestamp":1783633660801,"version":"3.55.0"},"reference-count":51,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Synthetic steroid hormone antagonists are clinically important compounds that regulate physiological responses to steroid hormones. The antagonists bind to the hormone receptors, which are ligand-inducible transcription factors, and modulate their gene-regulatory activities. In most instances, a steroid receptor, such as progesterone receptor (PR) or estrogen receptor (ER), is transcriptionally inactive when complexed with an antagonist and competitively inhibits transactivation of a target steroid-responsive gene by the cognate hormone-occupied receptor. In certain cellular and promoter contexts, however, antagonist-occupied PR or ER acquires paradoxical agonist-like activity. The cellular mechanisms that determine the switch from the negative to the positive mode of transcriptional regulation by an antagonist-bound steroid receptor are unknown. We now provide strong evidence supporting the existence of a cellular inhibitory cofactor that interacts with the B form of human PR (PR-B) complexed with the antiprogestin RU486 to maintain it in a transcriptionally inactive state. In the presence of unliganded thyroid hormone receptor (TR) or ER complexed with the antiestrogen 4-hydroxytamoxifen, which presumably sequesters a limiting pool of the inhibitory cofactor, RU486-PR-B functions as a transcriptional activator of a progesterone-responsive gene even in the absence of hormone agonist. In contrast, hormone-occupied TR or ER fails to induce transactivation by RU486-PR-B. Recent studies revealed that a transcriptional corepressor, NCoR (nuclear receptor corepressor), interacts with unliganded TR but not with liganded TR. Interestingly, coexpression of NCoR efficiently suppresses the partial agonistic activity of antagonist-occupied PR-B but fails to affect transactivation by agonist-bound PR-B. We further demonstrate that RU486-PR-B interacts physically with NCoR in vitro. These novel observations suggest that the inhibitory cofactor that associates with RU486-PR-B and represses its transcriptional activity is either identical or structurally related to the corepressor NCoR. We propose that cellular mechanisms that determine the switch from the antagonistic to the agonistic activity of RU486-PR-B involve removal of the corepressor from the antagonist-bound receptor so that it can effect partial but significant gene activation.<\/jats:p>","DOI":"10.1210\/mend.12.4.0089","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:29:48Z","timestamp":1389202188000},"page":"513-524","source":"Crossref","is-referenced-by-count":99,"title":["A Nuclear Receptor Corepressor Modulates Transcriptional Activity of Antagonist-Occupied Steroid Hormone Receptor"],"prefix":"10.1210","volume":"12","author":[{"given":"Xun","family":"Zhang","sequence":"first","affiliation":[{"name":"The Population Council and The Rockefeller University New York, New York 10021"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jeyakumar","sequence":"additional","affiliation":[{"name":"The Population Council and The Rockefeller University New York, New York 10021"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei","family":"Petukhov","sequence":"additional","affiliation":[{"name":"The Population Council and The Rockefeller University New York, New York 10021"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan K.","family":"Bagchi","sequence":"additional","affiliation":[{"name":"The Population Council and The Rockefeller University New York, New York 10021"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071614490357800_R1","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1126\/science.3283939","article-title":"The steroid and thyroid hormone receptor superfamily.","volume":"240","author":"Evans","year":"1988","journal-title":"Science"},{"key":"2020071614490357800_R2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.bi.63.070194.002315","article-title":"Molecular mechanisms of action of steroid\/thyroid receptor superfamily members.","volume":"63","author":"Tsai","year":"1994","journal-title":"Annu Rev Biochem"},{"key":"2020071614490357800_R3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","article-title":"The nuclear receptor superfamily: the second decade.","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"key":"2020071614490357800_R4","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0092-8674(95)90201-5","article-title":"Steroid hormone receptors: many actors in search of a plot.","volume":"83","author":"Beato","year":"1995","journal-title":"Cell"},{"key":"2020071614490357800_R5","first-page":"1167","article-title":"Nuclear receptor coactivators and corepressors.","volume":"10","author":"Horwitz","year":"1996","journal-title":"Mol Endocrinol"},{"key":"2020071614490357800_R6","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/339593a0","article-title":"Protein encoded by v-erbA functions as a thyroid hormone receptor antagonist.","volume":"339","author":"Damm","year":"1989","journal-title":"Nature"},{"key":"2020071614490357800_R7","first-page":"329","article-title":"Thyroid hormone aporeceptor represses T 3 inducible promoters and blocks activity of the retinoic acid receptor.","volume":"1","author":"Brent","year":"1989","journal-title":"The New Biologist"},{"key":"2020071614490357800_R8","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/j.1460-2075.1992.tb05140.x","article-title":"A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor.","volume":"11","author":"Baniahmad","year":"1992","journal-title":"EMBO J"},{"key":"2020071614490357800_R9","doi-asserted-by":"crossref","first-page":"5756","DOI":"10.1128\/MCB.14.9.5756","article-title":"Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor.","volume":"14","author":"Casanova","year":"1994","journal-title":"Mol Cell Biol"},{"key":"2020071614490357800_R10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1128\/MCB.15.1.76","article-title":"The \u03c44 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing.","volume":"15","author":"Baniahmad","year":"1995","journal-title":"Mol Cell Biol"},{"key":"2020071614490357800_R11","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1128\/MCB.16.5.1909","article-title":"Transcriptional silencing by unliganded thyroid hormone receptor \u03b2 requires a soluble corepressor that interacts with the ligand-binding domain of the receptor.","volume":"16","author":"Tong","year":"1996","journal-title":"Mol Cell Biol"},{"key":"2020071614490357800_R12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/377397a0","article-title":"Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor.","volume":"377","author":"Horlein","year":"1995","journal-title":"Nature"},{"key":"2020071614490357800_R13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/377451a0","article-title":"Polarity-specific activities of retinoic acid receptors determined by a co-repressor.","volume":"377","author":"Kurokawa","year":"1995","journal-title":"Nature"},{"key":"2020071614490357800_R14","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/377454a0","article-title":"A transcriptional co-repressor that interacts with nuclear hormone receptors.","volume":"377","author":"Chen","year":"1995","journal-title":"Nature"},{"key":"2020071614490357800_R15","first-page":"813","article-title":"Identification of TRACs (T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors.","volume":"10","author":"Sande","year":"1996","journal-title":"Mol Endocrinol"},{"key":"2020071614490357800_R16","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.270.5240.1354","article-title":"Sequence and characterization of a coactivator for the steroid hormone receptor superfamily.","volume":"270","author":"Onate","year":"1995","journal-title":"Science"},{"key":"2020071614490357800_R17","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1002\/j.1460-2075.1996.tb00736.x","article-title":"TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors.","volume":"15","author":"Voegel","year":"1996","journal-title":"EMBO J"},{"key":"2020071614490357800_R18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0092-8674(00)81118-6","article-title":"ACBP integrator complex mediates transcriptional activation and AP- 1 inhibition by nuclear receptors.","volume":"85","author":"Kamei","year":"1996","journal-title":"Cell"},{"key":"2020071614490357800_R19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1210\/mend.11.6.0003","article-title":"Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.","volume":"11","author":"Jeyakumar","year":"1997","journal-title":"Mol Endocrinol"},{"key":"2020071614490357800_R20","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1128\/MCB.16.10.5458","article-title":"A nuclear hormone receptor corepressor mediates trancriptional silencing by receptors with distinct repression domains","volume":"16","author":"Zamir","year":"1996","journal-title":"Mol Cell Biol"},{"key":"2020071614490357800_R20A","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/387043a0","article-title":"A complex containing NCoR, mSin 3 and histone deacetylase mediates transcriptional repression.","volume":"387","author":"Heinzel","year":"1997","journal-title":"Nature"},{"key":"2020071614490357800_R21","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/308850a0","article-title":"Common non-hormone binding component in nontransformed chick oviduct receptors of four steroid hormones.","volume":"308","author":"Joab","year":"1984","journal-title":"Nature"},{"key":"2020071614490357800_R22","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1126\/science.2781282","article-title":"Contragestion and other clinical applications of RU486, an antiprogesterone at the receptor.","volume":"245","author":"Baulieu","year":"1989","journal-title":"Science"},{"key":"2020071614490357800_R23","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1002\/j.1460-2075.1990.tb07613.x","article-title":"Agonistic and antagonistic activities of RU 486 on the functions of the human progesterone receptor.","volume":"9","author":"Meyer","year":"1990","journal-title":"EMBO J"},{"key":"2020071614490357800_R24","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1002\/j.1460-2075.1990.tb07469.x","article-title":"Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the antioestrogen 4-hydroxytamoxifen.","volume":"9","author":"Berry","year":"1990","journal-title":"EMBO J"},{"key":"2020071614490357800_R25","first-page":"146","article-title":"The molecular biology of RU 486. Is there a role for antiprogestins in the treatment of breast cancer?","volume":"13","author":"Horwitz","year":"1992","journal-title":"Endocr Rev"},{"key":"2020071614490357800_R26","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/336695a0","article-title":"Receptors bound to antiprogestin form abortive complexes with hormone responsive elements.","volume":"336","author":"Guichon-Mantel","year":"1988","journal-title":"Nature"},{"key":"2020071614490357800_R27","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/345547a0","article-title":"Identification of a functional intermediate in receptor activation in progesterone-dependent cell-free transcription.","volume":"345","author":"Bagchi","year":"1990","journal-title":"Nature"},{"key":"2020071614490357800_R28","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1128\/MCB.11.10.4998","article-title":"Progesterone enhances gene transcription by receptor free of heat shock proteins hsp90, hsp56, and hsp 70.","volume":"11","author":"Bagchi","year":"1991","journal-title":"Mol Cell Biol"},{"key":"2020071614490357800_R29","first-page":"21","article-title":"Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions.","volume":"8","author":"Tzukerman","year":"1994","journal-title":"Mol Endocrinol"},{"key":"2020071614490357800_R30","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1016\/S0021-9258(18)98344-4","article-title":"Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP.","volume":"268","author":"Sartorius","year":"1993","journal-title":"J Biol Chem"},{"key":"2020071614490357800_R31","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1073\/pnas.90.10.4441","article-title":"The progesterone antagonist RU 486 acquires agonist activity upon stimulation of cAMP signaling pathways.","volume":"90","author":"Beck","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071614490357800_R32","first-page":"296","article-title":"Alterations in the agonist\/antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: antiestrogen selectivity and promoter dependence.","volume":"8","author":"Fujimoto","year":"1994","journal-title":"Mol Endocrinol"},{"key":"2020071614490357800_R33","doi-asserted-by":"crossref","first-page":"20870","DOI":"10.1016\/S0021-9258(19)36867-X","article-title":"Modulation by vitamin B 6 of glucocorticoid receptor-mediated gene expression requires transcription factors in addi-tion to the glucocorticoid receptor.","volume":"268","author":"Allgood","year":"1993","journal-title":"J Biol Chem"},{"key":"2020071614490357800_R34","doi-asserted-by":"crossref","first-page":"12195","DOI":"10.1073\/pnas.93.22.12195","article-title":"The extreme C-terminus of progesterone receptor contains a transcriptional repressor domain that functions through a putative corepressor","volume":"93","author":"Xu","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071614490357800_R35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1210\/mend.11.6.0004","article-title":"The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain binding coactivator L7\/SPA and the corepressor NCoR or SMRT.","volume":"11","author":"Jackson","year":"1997","journal-title":"Mol Endocrinol"},{"key":"2020071614490357800_R36","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1210\/mend.11.6.0009","article-title":"Coactivator and corepressor regulation of the agonist\/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen.","volume":"11","author":"Smith","year":"1997","journal-title":"Mol Endocrinol"},{"key":"2020071614490357800_R37","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0092-8674(92)90234-4","article-title":"The mechanism of RU 486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor.","volume":"69","author":"Vegeto","year":"1992","journal-title":"Cell"},{"key":"2020071614490357800_R38","doi-asserted-by":"crossref","first-page":"19513","DOI":"10.1016\/S0021-9258(18)41805-4","article-title":"Hormone and antihormone induce distinct conformational changes which are cen-tral to steroid receptor activation.","volume":"267","author":"Allan","year":"1992","journal-title":"J Biol Chem"},{"key":"2020071614490357800_R39","doi-asserted-by":"crossref","first-page":"7567","DOI":"10.1073\/pnas.93.15.7567","article-title":"SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers","volume":"93","author":"Chen","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071614490357800_R40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.ge.25.120191.000513","article-title":"Transcription activation by estrogen and progesterone receptors.","volume":"25","author":"Gronemeyer","year":"1991","journal-title":"Annu Rev Genet"},{"key":"2020071614490357800_R41","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0092-8674(89)90031-7","article-title":"The human estrogen receptor has two independent nonacidic transcriptional activation functions.","volume":"59","author":"Tora","year":"1989","journal-title":"Cell"},{"key":"2020071614490357800_R42","first-page":"1347","article-title":"A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform.","volume":"8","author":"Sartorius","year":"1994","journal-title":"Mol Endocrinol"},{"key":"2020071614490357800_R43","author":"Deleted in proof"},{"key":"2020071614490357800_R44","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0092-8674(00)80218-4","article-title":"Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase.","volume":"89","author":"Nagy","year":"1997","journal-title":"Cell"},{"key":"2020071614490357800_R45","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/nar\/19.6.1227","article-title":"Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells.","volume":"19","author":"Klein-Hitpass","year":"1991","journal-title":"Nucleic Acids Res"},{"key":"2020071614490357800_R46","doi-asserted-by":"crossref","first-page":"10601","DOI":"10.1074\/jbc.270.18.10601","article-title":"Ligand modulates the interaction of thyroid hormone receptor \u03b2 with the basal transcription machinery.","volume":"270","author":"Tong","year":"1995","journal-title":"J Biol Chem"},{"key":"2020071614490357800_R47","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1128\/MCB.16.1.281","article-title":"Unliganded thyroid hormone receptor a can target TATA-binding protein for transcriptional repression.","volume":"16","author":"Fondell","year":"1996","journal-title":"Mol Cell Biol"},{"key":"2020071614490357800_R48","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1210\/endo.136.3.7867589","article-title":"When tamoxifen turns bad.","volume":"136","author":"Horwitz","year":"1995","journal-title":"Endocrinology"},{"key":"2020071614490357800_R49","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1210\/edrv-11-4-578","article-title":"Endocrine pharmacology of antiestrogens as antitumor agents.","volume":"11","author":"Jordan","year":"1990","journal-title":"Endocr Rev"},{"key":"2020071614490357800_R50","doi-asserted-by":"crossref","first-page":"14825","DOI":"10.1074\/jbc.271.25.14825","article-title":"Ligand-dependent cross-talk between steroid and thyroid hormone receptors.","volume":"271","author":"Zhang","year":"1996","journal-title":"J Biol Chem"}],"container-title":["Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/12\/4\/513\/10614347\/mend0513.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/12\/4\/513\/10614347\/mend0513.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:21:45Z","timestamp":1647908505000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mend\/article\/12\/4\/513\/2754352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,4,1]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/mend.12.4.0089","relation":{},"ISSN":["0888-8809","1944-9917"],"issn-type":[{"value":"0888-8809","type":"print"},{"value":"1944-9917","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,4,1]]}}}